Medical Mycology: Antifungal Resistance, Diagnosis, and Infection Control

Dear Colleagues,

Fungal infections have become increasingly prominent in recent years, affecting approximately 1.7 billion people annually. Additionally, around 1.5 million invasive fungal infections (IFIs) have been reported, with high mortality rates worldwide. In October 2022, the WHO published a priority list of fungi requiring special attention in terms of research and diagnosis. This critical priority group included Candida albicans, Candida auris, Aspergillus fumigatus, and Cryptococcus neoformans. The many current concerns include resistance to antifungals due to drug or environmental pressure, in addition to the emergence of new species (C. auris) or multi-resistant clones (C. parapsilosis). It is noteworthy that neglected fungal tropical diseases (mycetoma, chromoblastomycosis, paracoccidioidomycosis, and sporotrichosis) are also considered a serious threat to global health due to the difficulty in diagnosing, treating, and controlling new cases. Early and effective diagnosis is essential for optimal management and control of all these infections. The latter also involves controlling resistance through the development of new targets and new classes of antifungal agents, or the repositioning of commercial drugs with antimycotic potential. This Special Issue seeks original research and review articles that contribute to the understanding of antifungal resistance and discuss cutting-edge strategies for the diagnosis of fungal infections. Furthermore, we propose to improve the understanding of measures that, in the translational scope, should be listed for the control and prevention of fungal infections. We invite researchers to submit both original research and review articles for this Special Issue.

Prof. Dr. Reginaldo Gonçalves de Lima-Neto
Prof. Dr. Patrice Le Pape
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• medical mycology
• fungal diseases
• antifungal resistance
• diagnosis
• infection control